Second Annual UPMC Heart Valve Symposium

April 29, 2023

The UPMC Heart Valve Symposium will provide an immersive and interactive experience into one of the most rapidly advancing and exciting spaces in cardiovascular medicine and surgery — heart valve disease. Experts from the UPMC Heart and Vascular Institute will explore the continuum of structural heart disease from diagnosis, to work-up, to intervention, with a focus on the lifelong management of heart valve disease. Interactive didactic, panel discussions, and moderated broadcast of two recorded live structural heart cases will provide a deep dive into the latest advancements and best-practice management strategies, including the cutting-edge of transcatheter heart valve repair and replacement, minimally invasive and robotic-assisted valve surgery, and advanced imaging techniques. This course will also look to what the future has in store — novel technologies, therapies, and clinical trials. All members of the multi-disciplinary heart team, current and future, are invited to join us as we do a deep dive into heart valve disease!

Target Audience

This meeting is open to physicians (including family practitioners, internists, residents, cardiologists, cardiac surgeons, thoracic surgeons, and anesthesiologists), advanced practice providers, nurses, researchers, medical students, and other health care professionals involved in the care of patients with complex valve and structural heart disease.

Learning Objectives

The UPMC Heart Valve Symposium intends to fulfill the following learning objectives:
•             Increase understanding of screening, diagnosis, and treatment of aortic, mitral, and tricuspid valvular heart disease in various patient populations. 
•             Understand advanced modalities to image aortic, mitral, and tricuspid heart valves.
•             Increase knowledge of medical therapies and transcatheter and/or surgical interventions for treatment of valvular heart disease, and the risks and benefits of the different therapeutic options.
•             Enhance understanding of importance of the multi-disciplinary heart team approach to treatment of structural heart disease.
•             Recognize impact of social determinants of health on structural heart disease outcomes.
•             Conduct a deep dive into technical aspects of transcatheter and surgical interventions to manage aortic, mitral, and tricuspid heart valve disease.
•             Explore landmark, recent and upcoming clinical trials, and their impact on heart valve disease
•             Explore complex and challenging cases in structural heart disease patients and tactics and techniques for management.

Additional Information

AttachmentSize
PDF icon HVI530709_HeartValveTemp23_v6 AEK 4.28.23 820pm (002).pdf441.86 KB
Course summary
Available credit: 
  • 5.75 AAPA Category I CME
  • 5.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 5.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 5.75 Attendance
Course opens: 
01/01/2023
Course expires: 
12/31/2023
Event starts: 
04/29/2023 - 8:00am EDT
Event ends: 
04/29/2023 - 2:00pm EDT
Add to calendar: 

PDF icon Agenda

Live Virtual Educational Event

Course Directors
Ibrahim Sultan, MD
Associate Professor of Cardiothoracic Surgery
Surgical Director, UPMC Center for Heart Valve
Disease
Director, UPMC Center for Thoracic Aortic Disease
UPMC Heart and Vascular Institute

A.J. Conrad Smith, MD
Associate Professor of Medicine
Medical Director, UPMC Center for Heart Valve
Disease
Associate Chief of Cardiology for Diversity, Equity,
and Inclusion
Director, Cardiac Catheterization Labs
UPMC Heart and Vascular Institute

Hemal Gada, MD
President, UPMC Heart and Vascular Institute at
UPMC Harrisburg
Medical Director, Structural Heart Program
UPMC Heart and Vascular Institute, Central PA

PDF icon Program Faculty

Faculty Disclosure
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for the individuals listed below have been mitigated.
Danny Chu, MD: Consultant: Sanamedi, Inc.
Danny Chu, MD: Other: The Osler Institute
Danny Chu, MD: Other: Wolter Kluwer Health
Hemal Gada, MD: Grant/Research Support: Abbott
Hemal Gada, MD: Grant/Research Support: Bard
Hemal Gada, MD: Grant/Research Support: Boston Scientific
Hemal Gada, MD: Grant/Research Support: Medtronic
Hemal Gada, MD: Consultant: Abbott
Hemal Gada, MD: Consultant: Bard
Hemal Gada, MD: Consultant: Boston Scientific
Hemal Gada, MD: Consultant: Medtronic
Hemal Gada, MD: Speaker’s Bureau: Abbott
Hemal Gada, MD: Speaker’s Bureau: Bard
Hemal Gada, MD: Speaker’s Bureau: Boston Scientific
Hemal Gada, MD: Speaker’s Bureau: Medtronic
Bryan H. Goldstein, MD: Grant/Research Support: Medtronic
Bryan H. Goldstein, MD: Grant/Research Support: Edwards Life Sciences
Bryan H. Goldstein, MD: Consultant: Medtronic
Bryan H. Goldstein, MD: Consultant: W.L. Gore & Associates
Bryan H. Goldstein, MD: Consultant: PECA Labs
Bryan H. Goldstein, MD: Consultant: Mezzion Pharma
Sandeep Jain, MD: Grant/Research Support: Medtronic
Sandeep Jain, MD: Grant/Research Support: Abbott
Sandeep Jain, MD: Grant/Research Support: Boston Scientific
Dustin Kliner, MD: Consultant: Abbott Vascular
Dustin Kliner, MD: Speaker’s Bureau: Abbott Vascular
Jackie Kreutzer, MD: Grant/Research Support: Medtronic
Jackie Kreutzer, MD: Edwards Life Sciences: Medtronic
Jackie Kreutzer, MD: Consultant: Medtronic
Amber Makani, MD: Grant/Research Support: Shockwave
Paul Mahoney, MD: Consultant: Edwards Life Sciences
Paul Mahoney, MD: Consultant: Medtronic
Paul Mahoney, MD: Consultant: Abbott
Paul Mahoney, MD: Consultant: Boston Scientific
Paul Mahoney, MD: Consultant: Abiomed
Samir F. Saba, MD: Grant/Research Support: Abbott
Samir F. Saba, MD: Grant/Research Support: Boston Scientific
Samir F. Saba, MD: Consultant: Medtronic
Samir F. Saba, MD: Consultant: Boston Scientific
Ibrahim Sultan, MD: Grant/Research Support/Abbott
Ibrahim Sultan, MD: Grant/Research Support: AtriCure
Ibrahim Sultan, MD: Grant/Research Support: Artivion
Ibrahim Sultan, MD: Grant/Research Support: Boston Scientific
Ibrahim Sultan, MD: Grant/Research Support: Edwards Life Sciences
Ibrahim Sultan, MD: Grant/Research Support: Medtronic
Ibrahim Sultan, MD: Grant/Research Support: Z MEDICA
Catalin Toma, MD: Consultant: Medtronic
Catalin Toma, MD: Consultant: Phillips
Timothy Wong, MD: Grant/Research Support: Bristol Myers-Squibb
Timothy Wong, MD: Grant/Research Support: Cytokinetics
Timothy Wong, MD: Grant/Research Support: Tenaya Therapeutics
Timothy Wong, MD: Consultant: PCM Scientific (HCM Academy)

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 5.75 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 

Available Credit

  • 5.75 AAPA Category I CME
  • 5.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 5.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 5.75 Attendance

Acknowledgement of Commercial Support:

Educational Grant Support:
Abbott Laboratories
Edwards Lifesciences, LLC
Medtronic, Inc.
Bolton Medical, Inc. (trading as TERUMO AORTIC)

Exhibit Support:
Abbott Structural Heart
Artivion
Amgen
Boston Scientific
Bristol Myers Squibb
Medtronic
Zimmer Biomet
Edwards Life Sciences
Bristol Myers

Please login or register to take this course.

For more information, please contact Angela Kinnunen by email at kinnunenae@upmc.edu or phone 412-770-4949.